Find a TenderClosed
Published 10 Oct 2022, 11:06 BST

Official UK procurement notice

Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses

Official notice

Authority: CELL THERAPY CATAPULT LIMITED

ServicesOpen procedure
Published estimate£180,000exc. VAT
Submissions closed 10 Nov 2022

What is being bought

Published requirement description

Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV).

Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded.

A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3".

Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.

CPV: Design and execution of research and development · Laboratory services · Research and experimental development services · Research laboratory services

The lotProcurement structure

single lot · value published
Lot #1RenewalPublished value£180,000
Delivery: London
Extensions: The proposed contract will be for a period of up to 6 months, with the option to extend, subject to satisfactory performance and continued need, for three additional 6-month periods (6 months + 6 months + 6 months + 6 months). The contract length will not exceed 2 (two) years.Variant bids: not allowed

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Closed
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
10 Oct 2022, 11:06 BST
Last source update
10 Oct 2022, 11:06 BST
Award evaluation window
10 Nov 2022 – …
FTS notice number
2022/S 000-028371
Classification (CPV)
Design and execution of research and developmentLaboratory servicesResearch and experimental development servicesResearch laboratory services
Delivery area
London (UKI)
Official registry OCID
ocds-h6vhtk-037448 Find a Tender

How it was run

Official notice
Run through: portal not identified
Language: EN
Submission deadline
10 Nov 2022, 12:00 GMT
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bids opened
10 Nov 2022, 12:01 GMT
Detailed submission instructions & authority contactsFrom official release

Timeline

10 Oct 2022 → 10 Nov 2022 · 3 dates
  1. Notice published
    10 Oct 2022, 11:06 BST
  2. Submission deadline
    10 Nov 2022, 12:00 GMT
  3. Bids opened
    10 Nov 2022, 12:01 GMT

Contracting authority & participating public bodies

CELL AND GENE THERAPY CATAPULT

Contracting authorityBody governed by public lawHealth GB-COH: 10016023 12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND, LONDON, London, SE19RTContact email Published organisation website ↗

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.